INTEGRATED BIOPHARMA INC (INBP)

0.18USD +0.00% (+0.00)

Over 1M: +12.5%

Style
Area Line Line with markers Steps Candles Hollow candles Bars

Candles and bars need the day’s open, high and low, and need room to be drawn in: past about a year of trading a body is thinner than a hairline, so those three offer the longest window that fits instead.

0.16 0.17 0.18 0.19
7 Aug 12 Aug 17 Aug 20 Aug 25 Aug 28 Aug 2 Sep

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q4 '25 — Revenue: 14.2M Q4 '25 — Operating Income: 589K Q4 '25 — Operating Cash Flow: 591K Q1 '26 — Revenue: 12.7M Q1 '26 — Operating Income: 163K Q1 '26 — Operating Cash Flow: 1.3M Q2 '26 — Revenue: 11.3M Q2 '26 — Operating Income: -914K Q2 '26 — Operating Cash Flow: 617K Q3 '26 — Revenue: 10.1M Q3 '26 — Operating Income: -1.1M Q3 '26 — Operating Cash Flow: 517K 0 3.5M 7M 10.5M 14M 17.5M
Q4 '25 Q1 '26 Q2 '26 Q3 '26
Revenue Operating Income Operating Cash Flow

How it scores

For a valuation multiple, the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

2.7
SBC / sales 0.38%
OE margin 5.5%
Adj. EBITDA margin -1.6%
Oper. margin -2.6%
ROIC -7.4%
Accruals -8.3%
Asset turnover 1.8×
Capex / sales 0.39%
FCF margin 5.9%
ROA 3.0%
OCF margin 6.3%
Profit margin 1.7%
ROE 4.3%
EBITDA margin -2.0%
Gross margin 4.6%
ROCE -5.9%
OCF / EBIT —

5 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5
EV/OE -0.041×
EV/Sales -0.0022×
EV/GP -0.048×
FCF yield 50.8%
P/B 0.29×
P/C 0.96×
P/E 6.9×
Div. yield —
EV/EBIT —
Fwd P/E —
PEG —
Shareholder yield —

2 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

5.7
Cash-flow margin stability 1.8 pp
Gross margin stability across years 2.5 pp
Revenue growth in the worst year on record -11.5%
Prepaid revenue growth —
RPO / sales —
RPO growth —
Segment HHI —

3 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

6.5
Current ratio 3.3×
ND/EBITDA -52.6
Interest cover -10.3×
Cash / Debt 45.9×
Debt / Eq 0.0067×
Debt payback 0.0 yr
Equity / Assets 71.2%
F-score 7.9 pts
Net debt / Eq 0.0×
Payout 0.0%
Quick ratio 1.8×
Cash runway —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

1.0
Operating margin trend -2.0
Most recent margin move -6.4
Sales CAGR 4Y -3.8%
Sales/sh Y/Y -9.7%
EPS Y/Y +614.6%
Gross profit Y/Y +43.2%
Shares change +0.96%
Sales Q/Q -27.5%
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS next Y —

4 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.